esc 2022: the all-heart trial: allopurionol in the treatment of ischaemic heart disease
Published 2 years ago • 416 plays • Length 2:30Download video MP4
Download video MP3
Similar videos
-
4:45
esc 2022: the emperor-pooled trial: clinical benefits of sglt2i in heart failure | dr faiez zannad
-
5:35
esc 2022: the ascend trial: aspirin and omega-3 fatty acids in preventing heart failure
-
17:14
esc 2022 late-breaker discussion: the invictus trial
-
9:52
esc 2022: 3 trials that will change your practice with dr purvi parwani
-
7:03
esc 2022: 3 trials that will change your practice with preventive cardiologist, dr martha gulati
-
5:02
esc 2022: emperor-preserved & deliver meta-analysis: sglt2is in heart failure | dr vaduganathan
-
6:49:45
radcliffe premiere tv - esc 2022 coverage | day 1
-
9:03
how blood flows through the heart in 9 minutes | heart structure and circulatory system | high yield
-
5:00
esc 22: panther: p2y12i vs aspirin monotherapy in pts with cad with prof valgimigli
-
1:15
esc tv at #esccongress 2022 - all-heart
-
54:59
double jeopardy: coronary disease in patients undergoing tavi - europcr 2022
-
3:46
esc 2022: artificial intelligence detection of severe aortic stenosis | dr geoffrey strange
-
1:16
behind the heart | prof isla mackenzie
-
5:00
esc 2022: act: anti-coronavirus therapies to prevent progression of covid-19 | dr sanjit jolly
-
5:29
mineralocorticoid antagonism in heart failure | esc 2024
-
32:40
trial updates from esc 2022 - cardiology rounds
-
6:29
esc 2022: advent-hf: adaptive servo ventilation in patients with heart failure and sleep apnea
-
18:30
heart score
-
4:49
acc 22: results from a sub-study of the poise-3 trial | dr maura marcucci